Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baoji Xinnuo New Metal Materials is a Chinese manufacturer of titanium and titanium alloy materials used primarily in medical-device and aerospace applications. The company supplies titanium bar, wire, plate, pipe, and related semi-finished products, with a strong stated focus on orthopedic implants, surgical instruments, dental applications, and additive manufacturing feedstock. Its medical business appears to center on materials for spine screws, intramedullary nails, hip and knee joint implants, internal bone fixation systems, Kirschner wires, and dental implant materials rather than on developing proprietary therapeutics. XINNUO also highlights in-house R&D, quality systems, and joint research activity in high-performance titanium alloys. For a biotech or healthcare analyst, this is best classified as a healthcare-adjacent advanced materials manufacturer serving the medical device supply chain, not a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baoji Xinnuo New Metal Materials.